These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


428 related items for PubMed ID: 6014252

  • 1. [Gonadotropin and steroid hormone excretion during treatment with 1-alpha-methyl-5-alpha-androstan-17-beta-ol-3-one (mesterolone)].
    Laschet U, Laschet L, Paarmann HF.
    Arzneimittelforschung; 1966 Apr; 16(4):469-71. PubMed ID: 6014252
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Modus of hormonal excretion and hormonal effects of 1-alpha-methyl-5-alpha-androsten-17-beta-ol-3-on (mesterolon in women)].
    Abrahamsson L, Haagenrud A, Hackl H, Haglund V, Wassén A.
    Arch Gynakol; 1973 Jun 25; 215(2):157-69. PubMed ID: 4740965
    [No Abstract] [Full Text] [Related]

  • 4. [Excretion of pituitary and steroid hormones in breast cancer following pituitary irradiation].
    Izmaĭlova GE, Sharoukhova KS, Goncharova MG, Kuz'mina ZV, Murav'eva NI.
    Vestn Akad Med Nauk SSSR; 1972 Jun 25; 27(10):36-9. PubMed ID: 4641120
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [The importance of studying steroid and hypophyseal hormone excretion in patients with dyshormonal tumors].
    Sharoukhova KS.
    Vestn Akad Med Nauk SSSR; 1968 Jun 25; 23(3):63-8. PubMed ID: 5754742
    [No Abstract] [Full Text] [Related]

  • 7. [Indication and significance of hormone-analysis in gynecology].
    Runnebaum B.
    Gynakol Rundsch; 1973 Jun 25; 13():Suppl 1:24-33. PubMed ID: 4798929
    [No Abstract] [Full Text] [Related]

  • 8. Gonadotropin and steroid hormone excretion in trophoblastic neoplasia.
    Ishizuka N, Okamoto M, Tomoda Y.
    Obstet Gynecol; 1973 Jul 25; 42(1):1-11. PubMed ID: 4352641
    [No Abstract] [Full Text] [Related]

  • 9. [The treatment of postpubertal Leydig cell insufficiency with 1-alpha-methyl-5-alpha-androstan-17-beta-ol-3-one (Mesterolone)].
    Schirren C.
    Arzneimittelforschung; 1966 Apr 25; 16(4):463-5. PubMed ID: 6014249
    [No Abstract] [Full Text] [Related]

  • 10. [Neutral 17-ketosteroids, estrogens and gonadotropins and the urine of males with endocrine forms of sex dysfunction disorders].
    Nishchymenko OV.
    Fiziol Zh; 1972 Apr 25; 18(5):627-31. PubMed ID: 4656683
    [No Abstract] [Full Text] [Related]

  • 11. [Conjugated estrogens, estrogen excretion and antigonadotropic effect].
    Laschet U, Laschet L.
    Arzneimittelforschung; 1970 Apr 25; 20(4):542-5. PubMed ID: 4315906
    [No Abstract] [Full Text] [Related]

  • 12. Influences of long-term use of intrauterine devices on reproductive organs.
    Matsumoto S, Ito T, Shiozaki T, Iijima Y, Tamada T.
    Int J Fertil; 1968 Apr 25; 13(4):326-31. PubMed ID: 5700388
    [No Abstract] [Full Text] [Related]

  • 13. [Puberty and hormones].
    Hiroi M.
    Sanfujinka No Jissai; 1971 Mar 25; 20(3):215-25. PubMed ID: 4928200
    [No Abstract] [Full Text] [Related]

  • 14. The influence of antiandrogens on the excretion of FSH, LH AND 17-ketosteroids in males.
    Vosbeck K, Keller PJ.
    Horm Metab Res; 1971 Jul 25; 3(4):273-6. PubMed ID: 5129987
    [No Abstract] [Full Text] [Related]

  • 15. [Therapeutic effectiveness of protesticulin in patients with endocrine form of impotence].
    Nishchimenko OV, Il'chevich NV, Borisenko IuA.
    Vrach Delo; 1975 Jun 25; (6):33-5. PubMed ID: 1154733
    [No Abstract] [Full Text] [Related]

  • 16. [Effect of 1-alpha-methyl-5-alpha-androstane-17-beta-ol-3-one (mesterolone) on the excretion of steroids in man].
    Breuer H, Gütgemann D.
    Arzneimittelforschung; 1966 Jun 25; 16(6):759-62. PubMed ID: 6014588
    [No Abstract] [Full Text] [Related]

  • 17. [Pathogenesis of menstrual function disorders in endocraniosis].
    Lemeneva ZL, Karateeva NA.
    Probl Endokrinol (Mosk); 1972 Jun 25; 18(1):22-5. PubMed ID: 5061547
    [No Abstract] [Full Text] [Related]

  • 18. [The androgenic effect of 1-alpha-methyl-5-alpha-androstan-17-beta-ol-3-one in comparison with 17-alpha-methyl-delta-4-androsten-17-beta-ol-3-one].
    Weller O.
    Arzneimittelforschung; 1966 Apr 25; 16(4):465-6. PubMed ID: 6014250
    [No Abstract] [Full Text] [Related]

  • 19. [FSH and steroid hormone excretion in breast cancer during chemotherapy].
    Sokolova VD, Sharoukhova KS, Goncharova MG, Murav'eva NI, Smirnova KD.
    Vopr Onkol; 1972 Apr 25; 18(10):19-22. PubMed ID: 4197020
    [No Abstract] [Full Text] [Related]

  • 20. [Endocrine environment of chorionic tumor].
    Okamoto M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1971 May 25; 23(5):432-40. PubMed ID: 5104366
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.